UNUSUAL AMINO-ACIDS .3. ASYMMETRIC-SYNTHESIS OF 3-ARYLALANINES

被引:20
作者
TAUDIEN, S
SCHINKOWSKI, K
KRAUSE, HW
机构
[1] UNIV ROSTOCK E V,INST ORGAN KATALYSEFORSCH,BUCHBINDERSTR 5-6,O-2500 ROSTOCK,GERMANY
[2] BERLIN CHEM AG,O-1199 BERLIN,GERMANY
关键词
D O I
10.1016/S0957-4166(00)86017-6
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
21 (Z)-alpha-N-benzoylamino-beta-arylacrylic acids and their esters were prepared by known procedures and hydrogenated to the corresponding optically active alpha-benzoyl-beta-arylalanine derivatives with optical yields in the range of 82-95% ee using the cationic rhodium complex of ''PROPRAPHOS'' as the chiral catalyst No electronical influences of the substituents at the aryl moiety on the enantioselectivity were observed but a sterical one, proved by X-ray crystallographic analysis and computer-aided modellings. Deacylation of the hydrogenated spezies produced the hydrochlorides of the 3-arylalanines attended by a partial racemisation In this case the hydrogenation of urethane type protected dehydroaminoacid derivatives seems to be the alternative.
引用
收藏
页码:73 / 84
页数:12
相关论文
共 45 条
[1]  
ACHIWA K, 1989, Patent No. 336123
[2]   RECENT ADVANCES IN ASYMMETRIC-SYNTHESIS .2. [J].
APSIMON, JW ;
COLLIER, TL .
TETRAHEDRON, 1986, 42 (19) :5157-5254
[3]  
ARENAL I, 1981, AN QUIM C-ORG BIOQ, V77, P56
[4]   DIRECTED HOMOGENEOUS HYDROGENATION [J].
BROWN, JM .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1987, 26 (03) :190-203
[5]  
BRUNNER H, 1988, TOP STEREOCHEM, V18, P129
[6]   THE ISOMERIC 2-PHENYL-4-BENZYLIDENE-5-OXAZOLONES (AZLACTONES OF ALPHA-BENZAMIDOCINNAMIC ACID) AND RELATED COMPOUNDS [J].
BUCKLES, RE ;
FILLER, R ;
HILFMAN, L .
JOURNAL OF ORGANIC CHEMISTRY, 1952, 17 (02) :233-242
[7]  
CAPLAR V, 1982, COMPREHENSIVE ORGANO, V8, pCH53
[8]  
Carter H. E., 1941, J BIOL CHEM, V139, P255
[9]  
CATIVIELA C, 1983, AN QUIM C-ORG BIOQ, V79, P188
[10]   ABSORPTION AND METABOLISM OF NAFARELIN, A POTENT AGONIST OF GONADOTROPIN-RELEASING HORMONE [J].
CHAN, RL ;
HENZL, MR ;
LEPAGE, ME ;
LAFARGUE, J ;
NERENBERG, CA ;
ANIK, S ;
CHAPLIN, MD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (03) :275-282